APA (7th ed.) Citation

Tang, Q., Zhang, X., Zhu, X., Xu, H., Song, G., Lu, J., . . . Wang, J. (2024, September). Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. Cancer Medicine.

Chicago Style (17th ed.) Citation

Tang, Qinglian, et al. "Camrelizumab in Combination with Doxorubicin, Cisplatin, Ifosfamide, and Methotrexate in Neoadjuvant Treatment of Resectable Osteosarcoma: A Prospective, Single‐arm, Exploratory Phase II Trial." Cancer Medicine Sep. 2024.

MLA (9th ed.) Citation

Tang, Qinglian, et al. "Camrelizumab in Combination with Doxorubicin, Cisplatin, Ifosfamide, and Methotrexate in Neoadjuvant Treatment of Resectable Osteosarcoma: A Prospective, Single‐arm, Exploratory Phase II Trial." Cancer Medicine, Sep. 2024.